During the past decade, Neurological Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neurological Research Institute" are "Clinically Isolated Syndrome" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing-Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Neurological Research Institute" in a lesser frequency.

Most popular intervention types in "Neurological Research Institute" are "Biological" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Dalfampridine-ER 10mg" (1 trials), "Dalfampridine-ER 5mg" (1 trials), "Tovaxin" (1 trials) and "Tovaxin Autologous T cell vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurological Research Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Neurological Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neurological Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neurological Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".